BACKGROUND:Patients with diabetes and depression often have self-management needs that require between-visit support. This study evaluated the impact of telephone-delivered cognitive behavioral therapy (CBT) targeting patients' management of depressive symptoms, physical activity levels, and diabetes-related outcomes. METHODS:Two hundred ninety-one patients with type 2 diabetes and significant depressive symptoms (Beck Depression Inventory scores ≥ 14) were recruited from a community-based, university-based, and Veterans Affairs health care systems. A manualized telephone CBT program was delivered weekly by nurses for 12 weeks, followed by 9 monthly booster sessions. Sessions initially focused exclusively on patients' depression management and then added a pedometer-based walking program. The primary outcome was hemoglobinA1c levels measured at 12 months. Blood pressure was a secondary outcome; levels of physical activity were determined by pedometer readings; depression, coping, and health-related quality of life were measured using standardized scales. RESULTS: Baseline A1c levels were relatively good and there was no difference in A1c at follow-up. Intervention patients experienced a 4.26 mm Hg decrease in systolic blood pressure relative to controls (P=0.05). Intervention patients had significantly greater increases in step counts (mean difference, 1131 steps/d; P=0.0002) and greater reductions in depressive symptoms (58% remitted at 12 mo vs. 39%; P=0.002). Intervention patients also experienced relative improvements in coping and health-related quality of life. CONCLUSIONS: This program of telephone-delivered CBT combined with a pedometer-based walking program did not improve A1c values, but significantly decreased patients' blood pressure, increased physical activity, and decreased depressive symptoms. The intervention also improved patients' functioning and quality of life.
RCT Entities:
BACKGROUND:Patients with diabetes and depression often have self-management needs that require between-visit support. This study evaluated the impact of telephone-delivered cognitive behavioral therapy (CBT) targeting patients' management of depressive symptoms, physical activity levels, and diabetes-related outcomes. METHODS: Two hundred ninety-one patients with type 2 diabetes and significant depressive symptoms (Beck Depression Inventory scores ≥ 14) were recruited from a community-based, university-based, and Veterans Affairs health care systems. A manualized telephone CBT program was delivered weekly by nurses for 12 weeks, followed by 9 monthly booster sessions. Sessions initially focused exclusively on patients' depression management and then added a pedometer-based walking program. The primary outcome was hemoglobin A1c levels measured at 12 months. Blood pressure was a secondary outcome; levels of physical activity were determined by pedometer readings; depression, coping, and health-related quality of life were measured using standardized scales. RESULTS: Baseline A1c levels were relatively good and there was no difference in A1c at follow-up. Intervention patients experienced a 4.26 mm Hg decrease in systolic blood pressure relative to controls (P=0.05). Intervention patients had significantly greater increases in step counts (mean difference, 1131 steps/d; P=0.0002) and greater reductions in depressive symptoms (58% remitted at 12 mo vs. 39%; P=0.002). Intervention patients also experienced relative improvements in coping and health-related quality of life. CONCLUSIONS: This program of telephone-delivered CBT combined with a pedometer-based walking program did not improve A1c values, but significantly decreased patients' blood pressure, increased physical activity, and decreased depressive symptoms. The intervention also improved patients' functioning and quality of life.
Authors: Amy M Kilbourne; Charles F Reynolds; Chester B Good; Susan M Sereika; Amy C Justice; Michael J Fine Journal: Am J Geriatr Psychiatry Date: 2005-03 Impact factor: 4.105
Authors: Christina M van der Feltz-Cornelis; Jasper Nuyen; Corinne Stoop; Juliana Chan; Alan M Jacobson; Wayne Katon; Frank Snoek; Norman Sartorius Journal: Gen Hosp Psychiatry Date: 2010-05-15 Impact factor: 3.238
Authors: John W Williams; Wayne Katon; Elizabeth H B Lin; Polly H Nöel; Jason Worchel; John Cornell; Linda Harpole; Bridget A Fultz; Enid Hunkeler; Virginia S Mika; Jürgen Unützer Journal: Ann Intern Med Date: 2004-06-15 Impact factor: 25.391
Authors: Wayne J Katon; Michael Von Korff; Elizabeth H B Lin; Greg Simon; Evette Ludman; Joan Russo; Paul Ciechanowski; Edward Walker; Terry Bush Journal: Arch Gen Psychiatry Date: 2004-10
Authors: Lisa K Richardson; Leonard E Egede; Martina Mueller; Carrae L Echols; Mulugeta Gebregziabher Journal: Gen Hosp Psychiatry Date: 2008-09-11 Impact factor: 3.238
Authors: Mary de Groot; Jay H Shubrook; W Guyton Hornsby; Yegan Pillay; Kieren J Mather; Karen Fitzpatrick; Ziyi Yang; Chandan Saha Journal: Diabetes Care Date: 2019-05-21 Impact factor: 19.112
Authors: Laura J Damschroder; David E Goodrich; Hyungjin Myra Kim; Robert Holleman; Leah Gillon; Susan Kirsh; Caroline R Richardson; Lesley D Lutes Journal: Transl Behav Med Date: 2016-09 Impact factor: 3.046
Authors: Dori Rosenberg; Elizabeth Lin; Do Peterson; Evette Ludman; Michael Von Korff; Wayne Katon Journal: Gen Hosp Psychiatry Date: 2013-11-04 Impact factor: 3.238
Authors: Kristin L Schneider; Emily Panza; Barbara Handschin; Yunsheng Ma; Andrew M Busch; Molly E Waring; Bradley M Appelhans; Matthew C Whited; Jacey Keeney; Daniel Kern; Mihaela Blendea; Ira Ockene; Sherry L Pagoto Journal: Behav Ther Date: 2015-10-31
Authors: John D Piette; Ann-Marie Rosland; Nicolle S Marinec; Dana Striplin; Steven J Bernstein; Maria J Silveira Journal: Med Care Date: 2013-03 Impact factor: 2.983